Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Tofacitinib helped a woman regrow hair with no major side effects.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

EGFR inhibitors for lung cancer can cause severe skin issues.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Derinat helps extend hair growth by reducing harmful molecules in skin cells.

Most patients experienced significant but reversible hair loss during treatment.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

MSC exosome therapy improved hair quality in patients with acquired trichorrhexis nodosa.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Reporter characteristics affect detection of hair loss from cancer therapy.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.